4D Molecular Therapeutics (FDMT) Cash & Current Investments (2019 - 2026)
4D Molecular Therapeutics (FDMT) posted Cash & Current Investments of $361.33 million for Q2 2026, up 23.2% from $293.23 million a year earlier but down 7.6% from the prior quarter.
4D Molecular Therapeutics (FDMT) Cash & Current Investments (2019 - 2026) Analysis & Trends
At the end of FY2025, 4D Molecular Therapeutics' Cash & Current Investments came in at $402.66 million, down 5.2% from FY2024.
- Annual Cash & Current Investments shows a five-year compound annual growth rate of 7.8% (FY2020 to FY2025).
- In prior years, 4D Molecular Therapeutics' Cash & Current Investments was $424.88 million in FY2024 (+47.4%), $288.23 million in FY2023 (+35.0%), $213.55 million in FY2022 (-13.8%) and $247.78 million in FY2021 (-10.5%).
- Quarterly Cash & Current Investments has run from a low of $161.68 million in Q3 2021 to a high of $541.95 million in Q2 2024 over five years.
- On a year-over-year basis, Cash & Current Investments increased in four of the last eight quarters, with growth averaging 2.5%.
- The strongest year-over-year quarter for Cash & Current Investments in the past five years was Q1 2024, with growth of 162.4%; the weakest was Q2 2025, with a decline of 45.9%.
- According to Business Quant data, Cash & Current Investments for the three prior quarters was $390.89 million (Q1 2026), $402.66 million (Q4 2025) and $305.06 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.76 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 9.92 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.97 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 11.70 Bn |
| 10 | 4D Molecular Therapeutics | 960.62 Mn | -499.33 Mn | - | 361.33 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 361.33 Mn |
| Mar 31, 2026 | 390.89 Mn |
| Dec 31, 2025 | 402.66 Mn |
| Sep 30, 2025 | 305.06 Mn |
| Jun 30, 2025 | 293.23 Mn |
| Mar 31, 2025 | 321.44 Mn |
| Dec 31, 2024 | 424.88 Mn |
| Sep 30, 2024 | 501.89 Mn |
| Jun 30, 2024 | 541.95 Mn |
| Mar 31, 2024 | 525.91 Mn |
| Dec 31, 2023 | 288.23 Mn |
| Sep 30, 2023 | 319.66 Mn |
| Jun 30, 2023 | 310.34 Mn |
| Mar 31, 2023 | 200.45 Mn |
| Dec 31, 2022 | 213.55 Mn |
| Sep 30, 2022 | 227.72 Mn |
| Jun 30, 2022 | 241.09 Mn |
| Mar 31, 2022 | 236.15 Mn |
| Dec 31, 2021 | 247.78 Mn |
| Sep 30, 2021 | 161.68 Mn |
4D Molecular Therapeutics Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=FDMT&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "FDMT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=FDMT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();